The FASEB Journal · 2013 · 41 citations · 43 references
Life SciencesImmunologyMolecular BiologyImmunotherapyMolecular ImmunologyTransplant ImmunologyAntigen PresentationHistocompatibilityHistocompatibility AntigensHuman Leukocyte Antigen SystemMajor Histocompatibility ComplexTransplant ImmunotherapyGraft Survival EnhancementHla ImmunogenicityHla-g Mediated Immune ModulationHla-g-mediated Immune ModulationHuman Leukocyte Antigen-g ExpressionHuman Leukocyte AntigensRecipient Graft SurvivalSkin Graft Survival
The human leukocyte antigen (HLA)-G is a tolerogenic molecule, whose expression by allografts is associated with better acceptance. An increasing interest in producing HLA-G as a clinical-grade molecule for therapy use is impaired by its complexity and limited stability. Our purpose was to engineer simpler and more stable HLA-G-derived molecules than the full-length HLA-G trimolecular complex that are also tolerogenic, functional as soluble molecules, and compatible with good manufacturing practice (GMP) production conditions. We present two synthetic molecules: (α3-L)x2 and (α1-α3)x2 polypeptides. We show their capability to bind the HLA-G receptor LILRB2 and their functions in vitro and in vivo. The (α1-α3)x2 polypeptide proved to be a potent tolerogenic molecule in vivo: One treatment of skin allograft recipient mice with (α1-α3)x2 was sufficient to significantly prolong graft survival, and four weekly treatments induced complete tolerance. Furthermore, (α1-α3)x2 was active as a soluble molecule and capable of inhibiting the proliferation of tumor cell lines, as does the full length HLA-G trimolecular complex. Thus, the synthetic (α1-α3)x2 polypeptide is a stable and simpler alternative to the full-length HLA-G molecule. It can be produced under GMP conditions, it functions as a soluble molecule, and it is at least as tolerogenic as HLA-G in vivo.
43
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
Susan Kovats, Elliott K. Main, Clifford Librach et al. · Science · 1990 · 1.4K citations
Life Sciences, Genetics, Immunology +17
Zohair Selmani, Abderrahim Naji, Inès Zidi et al. · Stem Cells · 2007 · 1.1K citations · Full text
Nathalie Rouas‐Freiss, Rachel Bras‐Gonçalves, Catherine Menier et al. · Proceedings of the National Academy of Sciences · 1997 · 693 citations